Weleader Biomedical Co (ROCO:7713) FCF Margin %: 31.91% (As of Dec. 2025) — 179% Above Median


ROCO:7713 Weleader Biomedical Co Ltd ROCO:7713
47 GF Score
Price NT$70.10
! 5 Warning Signs
View Full Analysis

What is Weleader Biomedical Co FCF Margin %?

Weleader Biomedical Co ROCO:7713 -1.54% 47 FCF Margin % is 31.91% as of Dec. 2025, which is 179% above its 10-year median of 11.45. GuruFocus rates ROCO:7713 with a GF Score™ of 47/100. The stock has 5 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Weleader Biomedical Co ranks better than 70.78% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Weleader Biomedical Co's Free Cash Flow for the three months ended in Dec. 2025 was NT$94 Mil. Weleader Biomedical Co's Revenue for the three months ended in Dec. 2025 was NT$295 Mil. Therefore, Weleader Biomedical Co's FCF Margin % for the quarter that ended in Dec. 2025 was 31.91%.

As of today, Weleader Biomedical Co's current FCF Yield % is 3.12%.

The historical rank and industry rank for Weleader Biomedical Co's FCF Margin % or its related term are showing as below:

ROCO:7713' s FCF Margin % Range Over the Past 10 Years
Min: -36.82   Med: 11.45   Max: 25.46
Current: 8.97

During the past 6 years, the highest FCF Margin % of Weleader Biomedical Co was 25.46%. The lowest was -36.82%. And the median was 11.45%.

ROCO:7713's FCF Margin % is ranked better than
70.78% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -0.375 vs ROCO:7713: 8.97

Weleader Biomedical Co FCF Margin % Related Terms

Weleader Biomedical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Weleader Biomedical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Weleader Biomedical Co FCF Margin % Chart

Weleader Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 25.46 -36.82 12.35 10.54 8.97

Weleader Biomedical Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.02 11.43 3.13 -10.55 31.91

ROCO:7713 vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Weleader Biomedical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Weleader Biomedical Co FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Weleader Biomedical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Weleader Biomedical Co's FCF Margin % falls into.


ROCO:7713
47GF Score
Weleader Biomedical Co Ltd ROCO:7713
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Weleader Biomedical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Weleader Biomedical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=99.553/1109.3
=8.97 %

Weleader Biomedical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=94.187/295.19
=31.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 31.91% mean?
Weleader Biomedical Co (ROCO:7713) has a FCF Margin % of 31.91% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Weleader Biomedical Co and its competitors. This is 179% above median its historical median of 11.45. According to the industry distribution chart, Weleader Biomedical Co ranks #239 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 29.2%.
Is Weleader Biomedical Co's FCF Margin % too high?
Weleader Biomedical Co's current FCF Margin % of 31.91% is 179% above median its 10-year median of 11.45. Based on the distribution chart, Weleader Biomedical Co ranks #239 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Weleader Biomedical Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Weleader Biomedical Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Weleader Biomedical Co ranks #239 out of 818 companies for FCF Margin %. This puts Weleader Biomedical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Weleader Biomedical Co and its competitors. Weleader Biomedical Co's current FCF Margin % is 31.91%, which is 179% above median its own 10-year median of 11.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weleader Biomedical Co stock overvalued right now?
Weleader Biomedical Co (ROCO:7713) has a current FCF Margin % of 31.91%. The current FCF Margin % is 31.91%, which is 179% above median its 10-year median of 11.45. Weleader Biomedical Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Weleader Biomedical Co (ROCO:7713), the current FCF Margin % is 31.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Weleader Biomedical Co Business Description

Address No. 80, Minzu 1st Road, 19th Floor - 1 & 2, Sanmin District, Kaohsiung, TWN
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments. The reportable segments of the Group are: The Company, which includes sale of testing reagents, and provision of testing instruments and services; and Health Leader, which includes sale of dietary supplements and testing reagents, and provision of information and professional services. It derives majority revenue from the Company segment. Geographically, the company operates and generates revenue from Taiwan.
47GF Score

Get the complete analysis for ROCO:7713

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.10
Price